InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Roivant Sciences Ltd.

ROIV Clue Score19
Bermuda Fiscal year ends March CIK 0001635088 Results filed 6 Aug 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

118
Insider
Date
Role
Action
Shares
Price
Amount
Eric Venker
3 Nov 2026
President & Immunovant CEO
Sold on a plan
200,000
$36.31
$7.26M
Eric Venker
28 Oct 2026
President & Immunovant CEO
Sold on a plan
200,000
$36.59
$7.32M
Eric Venker
20 Oct 2026
President & Immunovant CEO
Sold on a plan
14,144
$35.42
$500.98K
Eric Venker
20 Oct 2026
President & Immunovant CEO
Sold on a plan
185,856
$35.09
$6.52M
Melissa B, Epperly
1 Oct 2026
Director
Sold after exercise
900
$36.57
$32.91K
Melissa B, Epperly
1 Oct 2026
Director
Sold after exercise
16,850
$36.08
$607.95K
Eric Venker
30 Sep 2026
President & Immunovant CEO
Sold after exercise
200,000
$36.62
$7.32M
Meghan Fitzgerald
15 Sep 2026
Director
Sold on a plan
400
$40.45
$16.18K
Meghan Fitzgerald
15 Sep 2026
Director
Sold on a plan
4,712
$39.68
$186.97K
Melissa B, Epperly
15 Sep 2026
Director
Sold on a plan
600
$40.38
$24.23K
Melissa B, Epperly
15 Sep 2026
Director
Sold on a plan
4,338
$39.65
$172.00K
Meghan Fitzgerald
8 Sep 2026
Director
Sold after exercise
20,000
$39.90
$798.00K
Eric Venker
28 Aug 2026
President & Immunovant CEO
Sold after exercise
33,818
$36.44
$1.23M
Eric Venker
28 Aug 2026
President & Immunovant CEO
Sold after exercise
166,182
$35.63
$5.92M
Mayukh Sukhatme
21 Aug 2026
President & CIO
Sold after exercise
144,756
$36.48
$5.28M
Mayukh Sukhatme
20 Aug 2026
President & CIO
Sold after exercise
17,519
$37.30
$653.46K
Mayukh Sukhatme
19 Aug 2026
President & CIO
Sold after exercise
172,899
$37.17
$6.43M
Mayukh Sukhatme
18 Aug 2026
President & CIO
Sold after exercise
31,801
$37.18
$1.18M
Mayukh Sukhatme
18 Aug 2026
President & CIO
Sold after exercise
105,141
$36.59
$3.85M
Mayukh Sukhatme
17 Aug 2026
President & CIO
Sold after exercise
284,707
$36.25
$10.32M
Mayukh Sukhatme
14 Aug 2026
President & CIO
Sold after exercise
243,177
$36.23
$8.81M
Eric Venker
27 Jul 2026
President & Immunovant CEO
Sold after exercise
200,000
$34.95
$6.99M
QVT Financial LP
30 Jun 2026
Director by Deputization
Sell indirect
12,380
$35.28
$436.77K
Daniel Allen Gold
30 Jun 2026
Director
Sell indirect
12,380
$35.28
$436.77K
Keith S Manchester
30 Jun 2026
Director
Sell
200,000
$35.45
$7.09M
Keith S Manchester
30 Jun 2026
Director
Sell indirect
12,380
$35.28
$436.77K
Meghan Fitzgerald
30 Jun 2026
Director
Sold after exercise
10,000
$34.90
$349.00K
QVT Financial LP
29 Jun 2026
Director by Deputization
Sell indirect
600,000
$34.59
$20.75M
QVT Financial LP
29 Jun 2026
Director by Deputization
Sell indirect
200,000
$34.44
$6.89M
Daniel Allen Gold
29 Jun 2026
Director
Sell indirect
600,000
$34.59
$20.75M
Daniel Allen Gold
29 Jun 2026
Director
Sell indirect
200,000
$34.44
$6.89M
Keith S Manchester
29 Jun 2026
Director
Sell indirect
600,000
$34.59
$20.75M
Keith S Manchester
29 Jun 2026
Director
Sell indirect
200,000
$34.44
$6.89M
Melissa B, Epperly
29 Jun 2026
Director
Sold after exercise
2,748
$34.71
$95.38K
Melissa B, Epperly
29 Jun 2026
Director
Sold after exercise
15,002
$34.32
$514.87K
Mayukh Sukhatme
26 Jun 2026
President & CIO
Sold after exercise
500,000
$34.08
$17.04M
QVT Financial LP
26 Jun 2026
Director by Deputization
Sell indirect
325,000
$34.07
$11.07M
QVT Financial LP
26 Jun 2026
Director by Deputization
Sell indirect
300,783
$33.92
$10.20M
Daniel Allen Gold
26 Jun 2026
Director
Sell indirect
325,000
$34.07
$11.07M
Daniel Allen Gold
26 Jun 2026
Director
Sell indirect
300,783
$33.92
$10.20M
Keith S Manchester
26 Jun 2026
Director
Sell indirect
325,000
$34.07
$11.07M
Keith S Manchester
26 Jun 2026
Director
Sell indirect
300,783
$33.92
$10.20M
Mayukh Sukhatme
25 Jun 2026
President & CIO
Sold after exercise
500,000
$34.13
$17.07M
Eric Venker
24 Jun 2026
President & Immunovant CEO
Sold after exercise
46,234
$33.51
$1.55M
Eric Venker
24 Jun 2026
President & Immunovant CEO
Sold after exercise
153,766
$33.05
$5.08M
Eric Venker
22 May 2026
President & Immunovant CEO
Sold after exercise
200,000
$30.27
$6.05M
Eric Venker
20 Apr 2026
President & Immunovant CEO
Sold after exercise
200,000
$29.59
$5.92M
Matthew Gline
16 Apr 2026
CEO
Sell
289,774
$29.16
$8.45M
Jennifer Humes
8 Apr 2026
Chief Accounting Officer
Sell
13,538
$28.37
$384.07K
Meghan Fitzgerald
26 Mar 2026
Director
Sold after exercise
70,000
$27.45
$1.92M
Eric Venker
17 Mar 2026
President & Immunovant CEO
Sold after exercise
200,000
$28.24
$5.65M
Melissa B, Epperly
16 Mar 2026
Director
Sell
41,861
$28.68
$1.20M
Frank Torti
23 Feb 2026
President and Vant Chair
Sold after exercise
587,390
$27.51
$16.16M
Frank Torti
20 Feb 2026
President and Vant Chair
Sold after exercise
1,012,610
$27.15
$27.49M
Frank Torti
19 Feb 2026
President and Vant Chair
Sold after exercise
1,400,000
$27.42
$38.39M
QVT Financial LP
13 Feb 2026
Director by Deputization
Sell indirect
225,000
$26.50
$5.96M
QVT Financial LP
13 Feb 2026
Director by Deputization
Sell indirect
150,784
$26.49
$3.99M
Daniel Allen Gold
13 Feb 2026
Director
Sell indirect
225,000
$26.50
$5.96M
Daniel Allen Gold
13 Feb 2026
Director
Sell indirect
150,784
$26.49
$3.99M
Keith S Manchester
13 Feb 2026
Director
Sell indirect
225,000
$26.50
$5.96M
Keith S Manchester
13 Feb 2026
Director
Sell indirect
150,784
$26.49
$3.99M
Eric Venker
13 Feb 2026
President & Immunovant CEO
Sold after exercise
200,000
$26.49
$5.30M
QVT Financial LP
12 Feb 2026
Director by Deputization
Sell indirect
275,000
$26.76
$7.36M
QVT Financial LP
12 Feb 2026
Director by Deputization
Sell indirect
150,000
$26.72
$4.01M
Daniel Allen Gold
12 Feb 2026
Director
Sell indirect
275,000
$26.76
$7.36M
Daniel Allen Gold
12 Feb 2026
Director
Sell indirect
150,000
$26.72
$4.01M
Keith S Manchester
12 Feb 2026
Director
Sell indirect
275,000
$26.76
$7.36M
Keith S Manchester
12 Feb 2026
Director
Sell indirect
150,000
$26.72
$4.01M
QVT Financial LP
11 Feb 2026
Director by Deputization
Sell indirect
425,000
$26.67
$11.33M
Daniel Allen Gold
11 Feb 2026
Director
Sell indirect
425,000
$26.67
$11.33M
Keith S Manchester
11 Feb 2026
Director
Sell indirect
425,000
$26.67
$11.33M
Mayukh Sukhatme
9 Feb 2026
President & CIO
Sold after exercise
339,441
$26.47
$8.99M
Eric Venker
12 Jan 2026
President & Immunovant CEO
Sold after exercise
200,000
$21.92
$4.38M
Mayukh Sukhatme
31 Dec 2025
President & CIO
Sold after exercise
1,018,995
$21.71
$22.12M
Mayukh Sukhatme
29 Dec 2025
President & CIO
Sold after exercise
311,873
$21.74
$6.78M
Eric Venker
24 Dec 2025
President & Immunovant CEO
Sold after exercise
75,000
$22.53
$1.69M
Eric Venker
23 Dec 2025
President & Immunovant CEO
Sold after exercise
200,000
$22.45
$4.49M
Richard Pulik
23 Dec 2025
CFO
Sold after exercise
146,731
$22.39
$3.29M
Richard Pulik
23 Dec 2025
CFO
Sold after exercise
260,000
$22.45
$5.84M
QVT Financial LP
17 Dec 2025
Director by Deputization
Sell indirect
189,538
$23.17
$4.39M
QVT Financial LP
17 Dec 2025
Director by Deputization
Sell indirect
155,076
$23.02
$3.57M
QVT Financial LP
17 Dec 2025
Director by Deputization
Sell indirect
432,718
$23.05
$9.97M
Keith S Manchester
17 Dec 2025
Director
Sell indirect
189,538
$23.17
$4.39M
Keith S Manchester
17 Dec 2025
Director
Sell indirect
155,076
$23.02
$3.57M
Keith S Manchester
17 Dec 2025
Director
Sell indirect
432,718
$23.05
$9.97M
Daniel Allen Gold
17 Dec 2025
Director
Sell indirect
189,538
$23.17
$4.39M
Daniel Allen Gold
17 Dec 2025
Director
Sell indirect
155,076
$23.02
$3.57M
Daniel Allen Gold
17 Dec 2025
Director
Sell indirect
432,718
$23.05
$9.97M
Mayukh Sukhatme
17 Dec 2025
President & CIO
Sold after exercise
26,831
$23.09
$619.53K
QVT Financial LP
16 Dec 2025
Director by Deputization
Sell indirect
642,282
$23.08
$14.82M
QVT Financial LP
16 Dec 2025
Director by Deputization
Sell indirect
275,000
$22.93
$6.31M
Keith S Manchester
16 Dec 2025
Director
Sell indirect
642,282
$23.08
$14.82M
Keith S Manchester
16 Dec 2025
Director
Sell indirect
275,000
$22.93
$6.31M
Daniel Allen Gold
16 Dec 2025
Director
Sell indirect
642,282
$23.08
$14.82M
Daniel Allen Gold
16 Dec 2025
Director
Sell indirect
275,000
$22.93
$6.31M
Vivek Ramaswamy
15 Dec 2025
10% owner
Sold after exercise
353,745
$22.05
$7.80M
Matthew Gline
15 Dec 2025
CEO
Sold after exercise
943,527
$21.68
$20.46M
Matthew Gline
15 Dec 2025
CEO
Sold after exercise
566,116
$21.68
$12.27M
Matthew Gline
15 Dec 2025
CEO
Sold after exercise
230,357
$21.68
$4.99M
Vivek Ramaswamy
12 Dec 2025
10% owner
Sold after exercise
1,975,858
$21.96
$43.39M
Vivek Ramaswamy
11 Dec 2025
10% owner
Sold after exercise
774,142
$21.64
$16.75M
Eric Venker
9 Dec 2025
President & Immunovant CEO
Sold after exercise
200,000
$20.85
$4.17M
QVT Financial LP
19 Nov 2025
Director by Deputization
Sell indirect
175,000
$20.24
$3.54M
QVT Financial LP
19 Nov 2025
Director by Deputization
Sell indirect
125,000
$20.16
$2.52M
QVT Financial LP
19 Nov 2025
Director by Deputization
Sell indirect
150,000
$20.20
$3.03M
QVT Financial LP
19 Nov 2025
Director by Deputization
Sell indirect
850,000
$20.25
$17.21M
Daniel Allen Gold
19 Nov 2025
Director
Sell indirect
175,000
$20.24
$3.54M
Daniel Allen Gold
19 Nov 2025
Director
Sell indirect
125,000
$20.16
$2.52M
Daniel Allen Gold
19 Nov 2025
Director
Sell indirect
150,000
$20.20
$3.03M
Daniel Allen Gold
19 Nov 2025
Director
Sell indirect
850,000
$20.25
$17.21M
Keith S Manchester
19 Nov 2025
Director
Sell indirect
175,000
$20.24
$3.54M
Keith S Manchester
19 Nov 2025
Director
Sell indirect
125,000
$20.16
$2.52M
Keith S Manchester
19 Nov 2025
Director
Sell indirect
150,000
$20.20
$3.03M
Keith S Manchester
19 Nov 2025
Director
Sell indirect
850,000
$20.25
$17.21M
Vivek Ramaswamy
17 Nov 2025
10% owner
Sell
539,650
$20.51
$11.07M
Vivek Ramaswamy
14 Nov 2025
10% owner
Sell
1,027,670
$20.33
$20.89M
Vivek Ramaswamy
13 Nov 2025
10% owner
Sell
287,283
$20.81
$5.98M
Eric Venker
7 Nov 2025
President & Immunovant CEO
Sold after exercise
200,000
$20.22
$4.04M

What was left out

Form 4 filings counted 99
Amendments (4/A) skipped 0
Filings about a different issuer 2
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 8
Sales straight out of an exercise 46
Sales at will 64
Transactions with no price 0
Shares from compensation/vesting 33,682,213
History held since 17 Oct 2017